Stay updated with breaking news from Xencor Chart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
07.11.2023 - Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases, today reported financial results for the third quarter ended ...
03.11.2023 - Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today presented data from multiple preclinical-stage XmAb programs at the ... Seite 1